S. Nosbarbera et al., EFFECT OF HYBRID PEPTIDES OF CECROPIN-A AND MELITTIN IN AN EXPERIMENTAL-MODEL OF BACTERIAL KERATITIS, Cornea, 16(1), 1997, pp. 101-106
Synthetic peptides, ranging from 12 to 18 residues, containing partial
sequences from natural cecropin A and melittin were tested for activi
ty in an experimental pseudomonas keratitis model in rabbits. In separ
ate experiments, two Pseudomonas aeruginosa strains: (a) a clinical is
olated strain, and (b) an American Type Culture Collection (ATCC) stra
in, were inoculated into the stroma of one cornea of each rabbit. Pept
ides were topically applied at 0.1% in phosphate-buffered saline (PBS)
and compared with PBS alone and 0.3% gentamicin eye drops. Clinical e
valuation, based on the McDonald-Shadduck scale, was performed during
a >48-h period after the bacterial inoculation. The peptide-treated an
imals showed significantly lower (p < 0.05) inflammatory signs and low
er anterior-segment bacterial damage compared with PBS-treated animals
, after the first 6 h. The antiinflammatory/antimicrobial activity was
non significantly different (p > 0.05) from that in animals treated w
ith gentamicin. We conclude that peptides keeping the sequence KWKLFKK
from cecropin A and at least the sequence VLKVL from melittin show pr
omise as novel agents in topical ocular therapy of bacterial keratitis
.